Fig. 3: Stabilization of TF mRNA by vimentin.

a RT-qPCR analyses of TF in various cellular systems transfected with a nontargeting control siRNA (Ctrl Si1) or an siRNA against vimentin (Vim Si1). b RT-qPCR analyses of TF in MDA-MB-231, EGF-treated MDA-MB-468, EGF-treated PMC42-LA and TGF-β1-treated A549 cells transfected with a vimentin siRNA (Vim Si1) or a control siRNA (Ctrl Si1) for 24 h and subsequently treated with actinomycin D for different time periods.